These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 35309354)
1. Role of the CXCL13/CXCR5 Axis in Autoimmune Diseases. Pan Z; Zhu T; Liu Y; Zhang N Front Immunol; 2022; 13():850998. PubMed ID: 35309354 [TBL] [Abstract][Full Text] [Related]
2. CXCL13 antibody for the treatment of autoimmune disorders. Klimatcheva E; Pandina T; Reilly C; Torno S; Bussler H; Scrivens M; Jonason A; Mallow C; Doherty M; Paris M; Smith ES; Zauderer M BMC Immunol; 2015 Feb; 16(1):6. PubMed ID: 25879435 [TBL] [Abstract][Full Text] [Related]
3. The CXCL13/CXCR5-chemokine axis in neuroinflammation: evidence of CXCR5+CD4 T cell recruitment to CSF. Harrer C; Otto F; Pilz G; Haschke-Becher E; Trinka E; Hitzl W; Wipfler P; Harrer A Fluids Barriers CNS; 2021 Aug; 18(1):40. PubMed ID: 34446066 [TBL] [Abstract][Full Text] [Related]
4. Increased expression of CXCR5 and CXCL13 in mice with experimental autoimmune myocarditis. Han FL; Liang F; Jiang TC; Liu M Eur Rev Med Pharmacol Sci; 2017 Apr; 21(8):1860-1867. PubMed ID: 28485792 [TBL] [Abstract][Full Text] [Related]
5. Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren's syndrome. Salomonsson S; Larsson P; Tengnér P; Mellquist E; Hjelmström P; Wahren-Herlenius M Scand J Immunol; 2002 Apr; 55(4):336-42. PubMed ID: 11967114 [TBL] [Abstract][Full Text] [Related]
6. Effects of CXCL13 inhibition on lymphoid follicles in models of autoimmune disease. Finch DK; Ettinger R; Karnell JL; Herbst R; Sleeman MA Eur J Clin Invest; 2013 May; 43(5):501-9. PubMed ID: 23517338 [TBL] [Abstract][Full Text] [Related]
7. The chemokine receptor CXCR5 is pivotal for ectopic mucosa-associated lymphoid tissue neogenesis in chronic Helicobacter pylori-induced inflammation. Winter S; Loddenkemper C; Aebischer A; Räbel K; Hoffmann K; Meyer TF; Lipp M; Höpken UE J Mol Med (Berl); 2010 Nov; 88(11):1169-80. PubMed ID: 20798913 [TBL] [Abstract][Full Text] [Related]
8. Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma. Vermi W; Lonardi S; Bosisio D; Uguccioni M; Danelon G; Pileri S; Fletcher C; Sozzani S; Zorzi F; Arrigoni G; Doglioni C; Ponzoni M; Facchetti F J Pathol; 2008 Nov; 216(3):356-64. PubMed ID: 18792075 [TBL] [Abstract][Full Text] [Related]
9. Diminished CXCR5 expression in peripheral blood of patients with Sjögren's syndrome may relate to both genotype and salivary gland homing. Aqrawi LA; Ivanchenko M; Björk A; Ramírez Sepúlveda JI; Imgenberg-Kreuz J; Kvarnström M; Haselmayer P; Jensen JL; Nordmark G; Chemin K; Skarstein K; Wahren-Herlenius M Clin Exp Immunol; 2018 Jun; 192(3):259-270. PubMed ID: 29453859 [TBL] [Abstract][Full Text] [Related]
10. The role of CXCR5 and its ligand CXCL13 in the compartmentalization of lymphocytes in thyroids affected by autoimmune thyroid diseases. Aust G; Sittig D; Becherer L; Anderegg U; Schütz A; Lamesch P; Schmücking E Eur J Endocrinol; 2004 Feb; 150(2):225-34. PubMed ID: 14763921 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. Bürkle A; Niedermeier M; Schmitt-Gräff A; Wierda WG; Keating MJ; Burger JA Blood; 2007 Nov; 110(9):3316-25. PubMed ID: 17652619 [TBL] [Abstract][Full Text] [Related]
13. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis. Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043 [TBL] [Abstract][Full Text] [Related]
14. Activation of CXCL13/CXCR5 axis aggravates experimental autoimmune cystitis and interstitial cystitis/bladder pain syndrome. Zhao J; Chen S; Yang C; Zhou M; Yang T; Sun B; Zhu J; Zhang H; Lu Q; Li L; Yang Z; Song B; Shen W; Yi S; Dai S Biochem Pharmacol; 2022 Jun; 200():115047. PubMed ID: 35452631 [TBL] [Abstract][Full Text] [Related]
15. CXCL13 expression and follicular dendritic cells in relation to B-cell infiltration in periodontal disease tissues. Nakajima T; Amanuma R; Ueki-Maruyama K; Oda T; Honda T; Ito H; Yamazaki K J Periodontal Res; 2008 Dec; 43(6):635-41. PubMed ID: 18624951 [TBL] [Abstract][Full Text] [Related]
16. T follicular helper cell subsets: a potential key player in autoimmunity. Kurata I; Matsumoto I; Sumida T Immunol Med; 2021 Mar; 44(1):1-9. PubMed ID: 32546108 [TBL] [Abstract][Full Text] [Related]
17. The CXCL13/CXCR5 Immune Axis in Health and Disease-Implications for Intrathecal B Cell Activities in Neuroinflammation. Harrer C; Otto F; Radlberger RF; Moser T; Pilz G; Wipfler P; Harrer A Cells; 2022 Aug; 11(17):. PubMed ID: 36078057 [TBL] [Abstract][Full Text] [Related]
18. Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity. Wong CK; Wong PT; Tam LS; Li EK; Chen DP; Lam CW J Clin Immunol; 2010 Jan; 30(1):45-52. PubMed ID: 19774453 [TBL] [Abstract][Full Text] [Related]
19. CXCL13/CXCR5 signaling axis in cancer. Hussain M; Adah D; Tariq M; Lu Y; Zhang J; Liu J Life Sci; 2019 Jun; 227():175-186. PubMed ID: 31026453 [TBL] [Abstract][Full Text] [Related]
20. CXCL13-CXCR5 axis: Regulation in inflammatory diseases and cancer. Wang B; Wang M; Ao D; Wei X Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188799. PubMed ID: 36103908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]